Lynparza

Medicinal product

(Invented) name

Lynparza

Active substance (s)

Olaparibas

Strength

150 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01XK01, olaparib

Marketing authorisation holder

AstraZeneca AB, Švedija

Date of authorisation

2014-12-16

Date of renewal

Documents

Lynparza kortelė pacientui.pdf

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Film-coated tablet	1 vnt.
Olaparibas	150 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
99742	85850	1085850	lizdinė plokštelė	N56		Receptinis	EU/1/14/959/004	Tiekiama	-	-	No	-	-
99743	85851	1085851	lizdinė plokštelė	N112 (2x56)		Receptinis	EU/1/14/959/005	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2014-12-16	Registruotas